SOUTH SAN FRANCISCO, CA, Neuron23, an early stage biotechnology company, has closed a $100 million Series C financing.
Neuron23 Grabs $100M in Series C
SOUTH SAN FRANCISCO, CA, Neuron23, an early stage biotechnology company, has closed a $100 million Series C financing.
